A phase 1b study of the OxPhos inhibitor ME-344 in combination with bevacizumab in refractory metastatic colorectal cancer.
| Autor: | Boland, Patrick M, Lenz, Heinz-Josef, Cusnir, Mike, Florou, Vaia, Pishvaian, Michael J., Cohen, Deirdre J., Ciombor, Kristen Keon, Winer, Arthur, Guo, Jessie Yanxiang, Algaze, Sandra, Wiley, Sandra E, Ghalie, Richard, Hochster, Howard S. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS222-TPS222, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|